Skip to content

Drug interactions

Fesoterodine + Lapatinib

Severity: Moderate

Fesoterodine and Lapatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lapatinib inhibits CYP3A4 and may raise exposure to the active metabolite of fesoterodine. This could increase antimuscarinic adverse effects, particularly in patients with reduced renal function or CYP2D6 poor metabolism.

What this interaction means in plain words

Fesoterodine and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Fesoterodine belongs to Genitourinary; Lapatinib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 by lapatinib reduces clearance of the fesoterodine active metabolite.

What to do

Monitor for antimuscarinic effects such as dry mouth, constipation and urinary retention. Limit fesoterodine to 4 mg daily if adverse effects develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fesoterodine and Lapatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fesoterodine with Lapatinib?

MediHelp rates the interaction as moderate. Fesoterodine and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lapatinib inhibits CYP3A4 and may raise exposure to the active metabolite of fesoterodine. This could increase antimuscarinic adverse effects, particularly in patients with reduced renal function or CYP2D6 poor metabolism.

How serious is the interaction between Fesoterodine and Lapatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for antimuscarinic effects such as dry mouth, constipation and urinary retention. Limit fesoterodine to 4 mg daily if adverse effects develop.

What other medicines interact with Fesoterodine?

MediHelp also lists interactions of Fesoterodine with, for example, Bethanechol, Clozapine, Levoketoconazole. The full list is on the Fesoterodine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in